Phase 2 Study of Yondelis in Men With Advanced Prostate Carcinoma
Latest Information Update: 12 Apr 2022
At a glance
- Drugs Trabectedin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 07 Apr 2014 According to ClinicalTrials.gov record (NCT00072670); the treatment arms are increased from one (0.58 mg/m2/day) to three (0.58 mg/m2/day OR 1.2 mg/m2/day OR 1.5 mg/m2/day).
- 07 Apr 2014 According to ClinicalTrials.gov record (NCT00072670); the treatment arms are increased from one (0.58 mg/m2/day) to three (0.58 mg/m2/day OR 1.2 mg/m2/day OR 1.5 mg/m2/day).
- 09 Feb 2009 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.